Journal of Environmental Pathology Toxicology and Oncology

Papers
(The median citation count of Journal of Environmental Pathology Toxicology and Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Construction and Characterization of Cadherin 6 (CDH6)-Targeting Chimeric Antigen Receptor (CAR) Modified T Cells41
Correlation of FBXO45 Expression Levels with Cancer Severity by ZEB1 Ubiquitin in Non-Small-Cell Lung Cancer37
Construction of a Liver Cancer Prognostic Model Based on Interferon-Gamma-Related Genes for Revealing the Immune Landscape27
LncRNA linc01105 inhibits gastric cancer growth and metastasis by regulating the miR-650/TCEA3 axis13
Bio-chemical Ferrous ions (Fe2+) Mediated Fenton Reaction: A Biological Prodigy for Curing and Developing Autoimmune Rheumatoid Arthritis and Cancer13
Treatment Strategy for Breast Benign Intraductal Papilloma: A Meta-Analysis13
10
Promising Action of Cannabinoids on ER Stress-Mediated Neurodegeneration: An In Silico Investigation9
Effects of RNA Modification "Writers" of GALNT2 on the Tumor Microenvironment in Cervical Squamous Cell Carcinoma9
A Review on Protease Inhibitors of Herbal Origin to Combat Malignancy9
Analysis of the Clinical Value of hsa_circ_0001955 in Papillary Thyroid Cancer Treated with 131 Iodine8
Complex Genomic Rearrangement Patterns in Malignant Pleural Mesothelioma due to Environmental Asbestos Exposure7
Ethyl Acetate Extract of Oratosquilla Inhibits the Growth of Nasopharyngeal Carcinoma through the Hippo Pathway7
Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer7
Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small-Cell Lung Cancer7
miR-125b-5p Suppresses Leukemia Cell Proliferation by Regulating MCL17
Comprehensive Investigation of m6A Regulators for Prognosis in Head and Neck Squamous Cell Carcinoma7
7
Identification of Lung Adenocarcinoma Subtypes by Using Growth Hormone-Releasing Hormone-Related Genes and Establishment of Signature to Predict Prognosis and Guide Immunother6
PA2G4P4 Promotes Glioma Cell Migration and Tumorigenesis through the PTEN/AKT/mTOR Signaling Pathway5
PRMT4 Reduced Erastin-Induced Ferroptosis in Nasopharyngeal Carcinoma Cisplatin-Resistant Cells by Nrf2/GPX4 Pathway5
Expression Profiles, Prognosis, and ceRNA Regulation of SRY-Related HMG-Box Genes in Stomach Adenocarcinoma5
A Review on Experimentally Proven Medicinal Plants and Their Constituents against Fluoride Toxicity4
A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes4
4
Histone-Lysine N-Methyltransferase 2D (KMT2D) Impending Therapeutic Target for the Management of Cancer: The Giant Rats Tail4
Expression and Significance of the Long Non-Coding RNA APTR in the Occurrence and Development of Lung Adenocarcinoma4
Index, Volume 41, 20224
Identification of Ion Channel-Associated Prognostic Biomarkers for Lung Adenocarcinoma3
Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin3
Silencing the lncRNA EBLN3P Improves Prognosis in Patients with Invasive Breast Cancer by Directly Targeting miR-144-3p3
Studies on the Therapeutic and Prognostic Biomarkers of Glioma Using a Novel Cuproptosis-Related IncRNA Signature and Validation in Glioma3
Histone methyltransferase EHMT2 promotes the progression of breast ductal carcinoma by regulating the Hippo pathway3
3
Anti-cancer Role of Ellagic Acid by Modulating the Altered PI3K/PTEN/Akt Pathway in Bladder Cancer2
Gene Variations of Chemokine and Chemokine Receptor CXCL12/CXCR4 in Lung Cancer2
2
Chemotherapeutic Drugs Endow Gastric Cancer Mesenchymal Stem Cells with Stronger Tumor-Promoting Ability2
Oncogenic Role of Heterogeneous Nuclear Ribonucleoprotein C in Multiple Cancer Types, with a Particular Focus on Lung Adenocarcinoma, Using a Pan-Cancer Analysis and Cell Line Experiments2
Sinigrin Impedes the Breast Cancer Cell Growth through the Inhibition of PI3K/AKT/mTOR Phosphorylation-Mediated Cell Cycle Arrest2
Prediction of prognosis, tumor microenvironment, and drug treatment of colorectal cancer based on retinoic acid-related genes2
INDEX2
LncRNA PTCSC1 promotes TRAIL resistance through FOXO3a pathway in HCT116 and SW480 cells1
Transcription Factor E2F1 Enhances Hepatocellular Carcinoma Cell Proliferation and Stemness by Activating GINS11
Mechanistic Episodes on SARS-CoV-2-Mediated Neurological Manifestations and Their Possible Therapeutic Interventions1
PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer1
1
STAT1 Mediates the Transcription of CircIFI30 and Promotes the Progression of Triple-Negative Breast Cancer by Up-Regulating CDCA41
Frequency of Healthy Control Genotype of VDR Gene Polymorphisms in the Saudi Population of the Ha'il Region: A Comparative Study with Worldwide Population1
Melatonin: A Potential Antineoplastic Agent in Breast Cancer1
PFKFB3 Regulates the Growth and Migration of Ovarian Cancer Cells through Pyroptosis and Warburg Effect Progression1
1
LncRNA LINC01278 Regulates the Prognosis and Related Mechanisms of Gastric Cancer by Targeting miR-129-5p1
lncRNA AGAP11 Suppresses Lung Adenocarcinoma Progression by miR-494-3p and Predicts Prognosis1
Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer1
1
LncRNA-miRNA/RBP-mRNA network involved in human triple-negative breast cancer: An integrated approach1
METTL14 Promotes Oral Squamous Cell Carcinoma Progression by Regulating the mRNA and m6A Levels of CALD11
Inhibition of interleukin-1 receptor-associated kinase-1 by pacritinib is a therapeutic strategy to overcome melanoma resistance1
Structural Features of Coronavirus and the COVID-19 Pandemic's Impact in India1
Differential microRNAs Expression during Cancer Development, and Chemoprevention by Natural Compounds: A Comprehensive Review1
Downregulation of miR-605-5p facilitates breast cancer progression and unfavorable prognosis1
0.033636093139648